» Articles » PMID: 2105195

Intracerebral Crises During Treatment of Diabetic Ketoacidosis

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1990 Jan 1
PMID 2105195
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Sixty-nine instances of intracerebral complications of diabetic ketoacidosis (DKA), including 29 unpublished occurrences, were analyzed to determine predictive factors, the frequency of other disorders resembling cerebral edema, the effectiveness of intervention to reduce intracranial pressure, and whether any etiologic considerations appeared valid. The review failed to implicate rate of hydration, tonicity of administered fluids, rate of correction of glycemia, or use of bicarbonate. Infants and young children (less than 5 yr of age) were disproportionately represented (33%), as were new-onset patients (62%). Approximately 20% of patients were found to have localized basilar edema, hemorrhage, thromboses, or infection by computed tomography scan or on postmortem examination. The histories of 50% of the patients suggested a period of dramatic neurological change preceding respiratory arrest (RA) during which intervention might be effective. Twenty-three patients were treated for increased intracranial pressure before RA; 13 patients survived in an independent functional state, and 3 survived in a severely disabled or vegetative state. Only 3 of the remaining 46 patients survived normally: 2 were untreated and never developed RA, and 1 was given mannitol at the onset of apnea. This review supports close neurological monitoring and intervention to reduce intracranial pressure when there are definite signs of neurological compromise. However, treatment appears to be successful in only 50% of patients who give sufficient warning for such intervention, and they comprised half of the study population. Therefore, prevention of DKA remains the most important goal to avoid intracerebral complications.

Citing Articles

Metabolic acidosis and sudden infant death syndrome: overlooked data provides insight into SIDS pathogenesis.

Goldwater P, Gebien D World J Pediatr. 2024; 21(1):29-40.

PMID: 39656413 PMC: 11814015. DOI: 10.1007/s12519-024-00860-9.


Impact of the COVID-19 Pandemic on Diabetic Ketoacidosis Patients Treated in a Pediatric Intensive Care Unit: A Single-Center Cross-Sectional Study.

Perak E, Mrcela D, Markic J Medicina (Kaunas). 2024; 60(11).

PMID: 39596960 PMC: 11596239. DOI: 10.3390/medicina60111775.


Uncovering Diaphragm Cramp in SIDS and Other Sudden Unexpected Deaths.

Gebien D, Eisenhut M Diagnostics (Basel). 2024; 14(20).

PMID: 39451647 PMC: 11506607. DOI: 10.3390/diagnostics14202324.


Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.

Sooy M, Pyle L, Alonso G, Broncucia H, Rewers A, Gottlieb P J Clin Endocrinol Metab. 2024; 110(1):e80-e86.

PMID: 38470864 PMC: 11651691. DOI: 10.1210/clinem/dgae158.


Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic.

Azova S, Liu E, Wolfsdorf J Pediatr Diabetes. 2023; 2023.

PMID: 38050487 PMC: 10695073. DOI: 10.1155/2023/5123197.